| Dr Yuri Arvan, MD | |
|
1322 Maplewood Ave Ste A, Ronceverte, WV 24970-8016 | |
| (304) 647-1186 | |
| (304) 647-3006 |
| Full Name | Dr Yuri Arvan |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 40 Years |
| Location | 1322 Maplewood Ave Ste A, Ronceverte, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184657280 | NPI | - | NPPES |
| 054 | Other | WV | MTST BCBS |
| 143283 | Other | WV | ANTHEM BCBS |
| 7439592 | Other | WV | AETNA |
| 010140501 | Other | WV | FIRST HEALTH |
| 3810000225 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 21586 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greenbrier Valley Medical Center | Ronceverte, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Camc Greenbrier Valley Medical Center Inc | 1254702962 | 36 |
| Greenbrier Physicians Inc | 3779476387 | 10 |
News Archive
Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The Obama administration prohibited the State of Indiana on Wednesday from carrying out a new state law that cuts off money for Planned Parenthood clinics providing health care to low-income women on Medicaid. The state law penalized Planned Parenthood because some of its clinics also perform abortions.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 7 days ago
| Entity Name | Greenbrier Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982770244 PECOS PAC ID: 3779476387 Enrollment ID: O20040206000389 |
News Archive
Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The Obama administration prohibited the State of Indiana on Wednesday from carrying out a new state law that cuts off money for Planned Parenthood clinics providing health care to low-income women on Medicaid. The state law penalized Planned Parenthood because some of its clinics also perform abortions.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 7 days ago
| Entity Name | Camc Greenbrier Valley Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588373872 PECOS PAC ID: 1254702962 Enrollment ID: O20230118000113 |
News Archive
Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The Obama administration prohibited the State of Indiana on Wednesday from carrying out a new state law that cuts off money for Planned Parenthood clinics providing health care to low-income women on Medicaid. The state law penalized Planned Parenthood because some of its clinics also perform abortions.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yuri Arvan, MD 1320 Maplewood Ave, Ronceverte, WV 24970-8016 Ph: () - | Dr Yuri Arvan, MD 1322 Maplewood Ave Ste A, Ronceverte, WV 24970-8016 Ph: (304) 647-1186 |
News Archive
Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.
Chemists and students in science and engineering at Oregon State University have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine - an enormous and deadly problem in the developing world.
The Obama administration prohibited the State of Indiana on Wednesday from carrying out a new state law that cuts off money for Planned Parenthood clinics providing health care to low-income women on Medicaid. The state law penalized Planned Parenthood because some of its clinics also perform abortions.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
› Verified 7 days ago
John J Ryan, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 101 Davis Stuart Rd, Ronceverte, WV 24970 Phone: 304-793-3937 Fax: 304-793-2203 |